ALVO
Alvotech
ALVO lost money over the past year, so it has no meaningful PE right now. Analysts expect earnings to recover and profitability to improve.
ALVO Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Under pressure | |
| Weak | |
| Weak |
ALVO's revenue, profitability, cash flow and balance sheet are all currently under pressure.
ALVO PE Valuation
ALVO has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 19x next year's earnings.
ALVO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect ALVO to return to profit, with revenue growing.
ALVO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.25 | — |
| Q2 2026 | -$0.63 | -432% |
| Q1 2026 | -$0.34 | -200% |
| Q4 2025 | $0.00 | +$0.83 |
| Q3 2025 | $0.21 | +$1.86 |
| Q3 2024 | -$1.65 | +$0.56 |
| Q1 2021 | -$4.90 | -$4.07 |
| Q4 2020 | -$0.69 | +$0.19 |
ALVO has swung to a loss: it lost $0.63 per share over the past year, after a profit the year before.
ALVO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $105.8M | -39% |
| Q1 2026 | $105.9M | -20% |
| Q4 2025 | $166.4M | +10% |
| Q3 2025 | $114M | +11% |
| Q2 2025 | $173.2M | -13% |
| Q1 2025 | $132.8M | +260% |
| Q4 2024 | $151.2M | +183% |
| Q3 2024 | $102.9M | +478% |
ALVO's revenue has slid since its 2024 peak: $106M last quarter, down 39% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -11% | -22 points |
| Q1 2026 | 9.1% | +1.1 points |
| Q4 2025 | 29% | +20 points |
| Q3 2025 | 1.2% | -11 points |
| Q2 2025 | 10% | -36 points |
| Q1 2025 | 8% | +139 points |
| Q4 2024 | 8.9% | +157 points |
| Q3 2024 | 12% | +511 points |
ALVO's operating margin was −11% last quarter, down 22 points from the same quarter a year ago.
ALVO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$47.7M | -213% |
| Q1 2026 | -$106.6M | -$95.8M |
| Q4 2025 | -$71.5M | -$1.2M |
| Q3 2025 | -$74.5M | +$11M |
| Q2 2025 | $42.1M | +$99.8M |
| Q1 2025 | -$10.8M | +$69.2M |
| Q4 2024 | -$70.3M | +$7.4M |
| Q3 2024 | -$85.5M | +$38.4M |
ALVO has burned cash in almost every quarter: −$300M over the past year, against −$124M the year before.
ALVO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +8% | +26.5M shares |
| 1 year | +14% | +43.4M shares |
| 3 years | +56% | +128M shares |
| 5 years | +1042% | +326M shares |
| Available history | +46% | +113M shares |
ALVO has 357M diluted shares, up 14% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
ALVO hasn't bought back shares in the past year.
ALVO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 200.4x | High |
| Q1 2026 | 23.3x | High |
| Q4 2025 | 8.8x | High |
| Q3 2025 | 11.3x | High |
| Q2 2025 | 5.4x | High |
| Q1 2025 | 8.6x | High |
| Q3 2022 | 8.1x | High |
ALVO's net debt is more than 20 years of its operating earnings (EBITDA), up from 5.4 years a year ago.
ALVO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 49.9 | Neutral |
| Stochastic | 40.7 | Neutral |
ALVO's weekly RSI is 50 (neutral) and its Stochastic is 41 (neutral).
ALVO PE vs Healthcare Sector
| Metric | ALVO | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
ALVO has no meaningful PE right now: it lost money over the past year.
ALVO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $5.09 | 8.3% below |
| 20 week MA | $4.60 | 1.5% above |
| 50 week MA | $4.33 | 7.9% above |
| 100 week MA | $6.96 | 33% below |
| 200 week MA | $9.28 | 50% below |
ALVO's trend is mixed: it's above two of its five weekly moving averages, and 50% below its 200-week average.
ALVO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2022 | $9.70 | $10.0 | +3.1% |
| 2023 | $10.0 | $11.5 | +15% |
| 2024 | $11.5 | $12.7 | +10% |
| 2025 | $12.7 | $5.26 | -58% |
| 2026 YTD | $5.26 | $4.67 | -11% |
ALVO has finished higher in three of the last four years. It's down 11% so far in 2026.